Anne-Marie de Groot
Nessuna posizione attualmente
Profilo
Anne-Marie de Groot worked as the Head of Clinical Supply Chain Strategic Management at Janssen Pharmaceuticals, Inc. from 2016 to 2019.
She also served as the Chief Ethics & Compliance Officer at Pharming Group NV from 2020 to 2021.
Prior to her professional experience, she obtained an undergraduate degree from Stichting Hogeschool Leiden.
Precedenti posizioni note di Anne-Marie de Groot
| Società | Posizione | Fine |
|---|---|---|
| PHARMING GROUP N.V. | Compliance Officer | 01/05/2021 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/01/2019 |
Formazione di Anne-Marie de Groot
| Stichting Hogeschool Leiden | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Anne-Marie de Groot
